FY 2021 Supplemental Funding for Hypertension (NHCI-HC)


The Department of Health and Human Services (HHS) Health Resources and Services Administration (HRSA) and Office of Minority Health (OMH) are partnering through the National Hypertension Control Initiative: Addressing Disparities among Racial and Ethnic Minority Populations (HTN Initiative). Through this initiative, HRSA plans to offer $60 million in fiscal year 2021 in supplemental funding to health centers receiving Health Center Program operational grant (H80) funding that meet specified hypertension criteria:

  • Achieved blood pressure control in less than 58.9 percent of patients 18 to 85 years of age who have been diagnosed with hypertension; and
  • Served at least 100 patients 18 to 85 years of age who have been diagnosed with hypertension.

Award recipients will use NHCI-HC funds and other available resources to:

  • Conduct outreach and engage patients with uncontrolled hypertension to participate in the HTN Initiative;
  • Fully participate in T/TA activities offered in support of your NHCI-HC award;
  • Ensure access to and support use of Bluetooth or wireless-enabled Self-Measured Blood Pressure (SMBP) devices for a majority of your patients with hypertension, and use their data to inform hypertension treatment plans; and
  • Collect and share data to support participation in initiative evaluation and reporting activities.

Request for Funding:

Funding will be awarded under the same sub-programs and proportions as your H80 award. HRSA anticipates using a formula that considers the number of adult patients with hypertension. Use the following calculation to develop your funding request:

$90,000 + $60 per adult patient with uncontrolled hypertension reported in the 2019 Uniform Data System (UDS)


On or about November 16, 2020, HRSA sent an email to all H80 award recipients via the individuals registered as H80 project director, business official, and authorizing official in EHBs. The email provides a unique submission access link and passcode. The email also provides your H80 sub-program proportions to allow you to calculate the distribution of your NHCI-HC budget request correctly across your sub-program funding streams.

Your submission is due through EHBs by 5:00 pm ET on December 4, 2020.

The EHBs User Guide provides step-by-step instructions for completing your submission. The submission components are:

  • Application for Federal Assistance (SF-424)
    • Budget Information Form (SF-424A)
    • Project Narrative and Project Description | Example (PDF – 92 KB)
    • Budget Narrative with Personnel Justification Table | Example (PDF – 290 KB)
  • Project Overview Form
  • Project Plan Form | Example (PDF – 166 KB)

As appropriate, you may also submit:

  • Equipment List Form (if equipment costs are included in your budget request) | Example (PDF – 193 KB)
  • Indirect Cost Rate Agreement (if new or updated)
  • Other documents (up to five files may be uploaded)


Submission Information

Contact the NHCI-HC Technical Assistance Team

Complete the BPHC Contact Form

Select “Applications” for Issue Type and “National Hypertension Control Initiative (NHCI-HC)” for issue subtype

Business, Administrative, and Fiscal Questions

Contact Grants Management Specialist Mona Thompson

HRSA Electronic Handbooks Support

Health Center Program Support

877-464-4772 (select option 1) or complete the BPHC Contact Form

CMS is announcing the Request for Application (RFA) open period (November 19, 2020 to January 3, 2021) for the Value in Opioid Use Disorder Treatment (ViT) Initiative

The Centers for Medicare & Medicaid Services (CMS), Center for Medicare and Medicaid Innovation (Innovation Center) is announcing the Request for Application (RFA) for a new initiative that aims to increase access to opioid use disorder (OUD) treatment services to eligible Medicare Fee-For-Service (FFS) beneficiaries, including those dually eligible for Medicare and Medicaid. This is one of a number of new initiatives required under The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (the SUPPORT Act). The statute makes available $10,000,000 each of fiscal years 2021-2024 for demonstration payments.

Value in Opioid Use Disorder Treatment (Value in Treatment) is a four-year demonstration that creates two new payments to participating providers: 1) a per beneficiary per month care management fee (CMF) and 2) a performance-based incentive payment. These new payments will be made in addition to the OUD treatment services Medicare currently covers.

Value in Treatment participants may use these payments to furnish certain patient-centered OUD treatment services and have a reasonable expectation of improving or maintaining the health or overall function of participating beneficiaries.

The demonstration is open to a wide range of eligible participants, including:

  • Individual physicians
  • Group practices comprised of at least one physician or Nurse Practitioner
  • Hospital outpatient departments
  • Federally qualified health centers
  • Rural health clinics
  • Community mental health centers
  • Certified community behavioral health clinics (CCBHCs)
  • Opioid treatment programs (OTPs)
  • Critical Access Hospitals (CAHs)

CMS encourages eligible participants to apply to the demonstration from November 19, 2020 to January 3, 2021. Selected participants are expected to implement the demonstration by April 1st, 2021, at which point demonstration payments will also start.

For more information, and to access the Request for Application (RFA), please visit: https://innovation.cms.gov/innovation-models/value-in-treatment-demonstration